Search research articles
Contact Us
Filters
Showing results (71-80 of 139) with videos related to
Page
of 14
Sort By:
BMC Medical Informatics and Decision Making
|
July 26, 2013
Designing a multifaceted survivorship care plan to meet the information and communication needs of breast cancer patients and their family physicians: results of a qualitative pilot study
Rashida Haq, Lineke Heus, Natalie A Baker, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 5, 2020
COVID's Impact on Radiation Oncology: A Latin American Survey Study
David Martinez, Gustavo J Sarria, Daniel Wakefield, et al.
Clinical and Translational Radiation Oncology
|
November 24, 2025
Radiotherapy access in Latin America: Socio-economic determinants and equity challenges socio-economic determinants in Latin America for radiotherapy
Gustavo R Sarria, Santiago Torales, Florencia Rossi, et al.
JMIR Formative Research
|
June 30, 2026
Iterative Multidisciplinary Development and Evaluation of a Patient-Facing SDoH Chatbot Using Synthetic Data Simulation
Anna M Maw, Alexander Lupi, Rachel Johnson-Koenke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 20, 2025
Current availability of radiotherapy devices in Peru and artificial intelligence-based analysis for constructing a nationwide implementation plan
Gustavo R Sarria, Dante Baldeon, Eduardo Payet, et al.
Breast (Edinburgh, Scotland)
|
March 14, 2026
Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- bone-only metastatic breast cancer
Adam Brufsky, Rachel M Layman, Xianchen Liu, et al.
Breast (Edinburgh, Scotland)
|
April 5, 2026
Corrigendum to "Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- bone-only metastatic breast cancer" [The Breast 86 (2026) 104744]
Adam Brufsky, Rachel M Layman, Xianchen Liu, et al.
Proceedings of Machine Learning Research
|
May 29, 2026
Mind the Performance Gap: Examining Dataset Shift During Prospective Validation
Erkin Ötleş, Jeeheh Oh, Benjamin Li, et al.
Future Oncology (London, England)
|
June 22, 2026
Comparison of survival outcomes for people with HR+/HER2- metastatic breast cancer who received palbociclib, ribociclib, or abemaciclib with an aromatase inhibitor: a plain language summary
Hope S Rugo, Rachel M Layman, Filipa Lynce, et al.
Biomaterials
|
December 14, 2020
Cellular remodeling of fibrotic conduit as vascular graft
Xuefeng Qiu, Benjamin Li-Ping Lee, Sze Yue Wong, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 139) with videos related to
Sort By:
Page
of 14
BMC Medical Informatics and Decision Making
|
July 26, 2013
Designing a multifaceted survivorship care plan to meet the information and communication needs of breast cancer patients and their family physicians: results of a qualitative pilot study
Rashida Haq, Lineke Heus, Natalie A Baker, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 5, 2020
COVID's Impact on Radiation Oncology: A Latin American Survey Study
David Martinez, Gustavo J Sarria, Daniel Wakefield, et al.
Clinical and Translational Radiation Oncology
|
November 24, 2025
Radiotherapy access in Latin America: Socio-economic determinants and equity challenges socio-economic determinants in Latin America for radiotherapy
Gustavo R Sarria, Santiago Torales, Florencia Rossi, et al.
JMIR Formative Research
|
June 30, 2026
Iterative Multidisciplinary Development and Evaluation of a Patient-Facing SDoH Chatbot Using Synthetic Data Simulation
Anna M Maw, Alexander Lupi, Rachel Johnson-Koenke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 20, 2025
Current availability of radiotherapy devices in Peru and artificial intelligence-based analysis for constructing a nationwide implementation plan
Gustavo R Sarria, Dante Baldeon, Eduardo Payet, et al.
Breast (Edinburgh, Scotland)
|
March 14, 2026
Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- bone-only metastatic breast cancer
Adam Brufsky, Rachel M Layman, Xianchen Liu, et al.
Breast (Edinburgh, Scotland)
|
April 5, 2026
Corrigendum to "Real-world effectiveness of palbociclib in combination with an aromatase inhibitor in HR+/HER2- bone-only metastatic breast cancer" [The Breast 86 (2026) 104744]
Adam Brufsky, Rachel M Layman, Xianchen Liu, et al.
Proceedings of Machine Learning Research
|
May 29, 2026
Mind the Performance Gap: Examining Dataset Shift During Prospective Validation
Erkin Ötleş, Jeeheh Oh, Benjamin Li, et al.
Future Oncology (London, England)
|
June 22, 2026
Comparison of survival outcomes for people with HR+/HER2- metastatic breast cancer who received palbociclib, ribociclib, or abemaciclib with an aromatase inhibitor: a plain language summary
Hope S Rugo, Rachel M Layman, Filipa Lynce, et al.
Biomaterials
|
December 14, 2020
Cellular remodeling of fibrotic conduit as vascular graft
Xuefeng Qiu, Benjamin Li-Ping Lee, Sze Yue Wong, et al.
Page
of 14